World Biosimilar Congress USA


Cost-effective biologics for payers, prescribers and patients

A multi-streamed, co-located conference & technology exhibition

March 2–4 2020 | San Diego, USA



50+ Exhibitors  |  250+ Speakers  |  1000+ Attendees


Key Speakers in 2019

Sheila Frame, Vice President and Head of Biopharmaceuticals, Sandoz Sheila Frame
VP and Head of Biopharmaceuticals

Bradley J. Scott, Senior Clinical Evaluator, Clinical Evaluation Division - Hematology / Oncology, HPFB, Health Canada (CONFIRMED) Bradley J. Scott
Senior Clinical Evaluator, Clinical Evaluation Division - Hematology / Oncology, HPFB
Health Canada

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/University of Illinois Sarfaraz Niazi
Chairman, Professor
Karyo Biologics/University of Illinois


Hubert Chen, Chief Medical & Scientific Officer, Pfenex Hubert Chen
Scientific & Medical Advisor

Bruce Leicher, Senior Vice President and General Counsel, Momenta Pharmaceuticals, Inc. Bruce Leicher
Senior Vice President and General Counsel
Momenta Pharmaceuticals, Inc.

Julio Baez, Former Head Technology, Cipla Biotech Julio Baez
Former Head Technology
Cipla Biotech

Peg Ford, President, Ovarian Cancer Alliance of San Diego Peg Ford
Ovarian Cancer Alliance of San Diego

Maggie Dolan, Associate Director market Access EU Biosimilars, Biogen Maggie Dolan
Associate Director market Access EU Biosimilars

Bryan Kim, Vice President, Business Development, Samsung Bioepis Bryan Kim
Vice President, Business Development
Samsung Bioepis


Congress Topics







It’s not just about the conference sessions, our Congress recognises the importance of networking.

With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.


The World Biosimilar Congress USA brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.

The event looks at commercialising and pushing forward the entire developmental pipeline as well as focusing on the hottest new individual therapeutics.


Exhibit at Work 2.0

This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.

Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.


2019 Advisory Board

The agenda was shaped by an industry advisory board, with members including


Roy Baynes, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)

Roy Baynes
SVP and Head Global Clinical Development, Chief Medical Officer
Merck, Sharp & Dohme (MSD)

Hans Klingemann, Vice President of Research and Development, NantKwest

Hans Klingemann
Vice President of Research and Development

Mark Chiu, Associate Director, Multispecific Biologics Engineering, Janssen Research & Development

Mark Chiu
Associate Director, Multispecific Biologics Engineering
Janssen Research & Development

Michael DeRidder, Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, GSK

Michael DeRidder
Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy

Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury
Senior Director and Head, Antibody Discovery
Sanofi Genzyme

Kevin Johnson, Partner, Medicxi

Kevin Johnson

Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Alexey Rak
Head of Bio Structure and Biophysics


Who Attends


AbbVie Abzena ADC Therapeutics Alligator Bioscience Amgen AstraZeneca Biogen Biosim Spanish Association of Biosimilars Boehringer Ingelheim Bristol Myers Squibb Cancer Research UK Cinfa Biotech GmbH Dr. Reddy's Laboratories SA. Duke University Medical Centre Eli Lilly & Co European Molecular Biology Laboratory European Patent Office European Specialist Nurses Organisations Ferrer International Fraunhofer IME Gedeon Richter Goldstein & Fox GSK HPAPI Project Services Ltd Janssen Libbs Pharmaceutica Lonza mAbs Macrogenics Maverick Therapeutics MedImmune Merck Merck, Sharp & Dohme (MSD) Napp pharmaceuticals NAPP Pharmaceuticals NBE Therapeutics NHS NIBR NICE NIHR Clinical Research Network (NIHR CRN) Norwegian Medicines Agency Novartis NovImmune NxR Biotechnologies Opsona Therapeutics Oril Industrie Ossianix PAREXEL Paul Ehrlich Institute Pfizer Biotherapeutics Pieris Pharmaceuticals Pierre Fabre Prima BioMed Roche Roche S.A.Toral SafeBridge Sandoz Biopharmaceuticals Sandoz Sanofi Sanofi R&D Sanquin Seattle Genetics Technische Universität Braunschweig Teva Pharmaceuticals The Royal Marsden NHS Foundation Trust Therapeomic TU Wien UCB Celltech University of Cambridge University of Denmark University of Messina – Italy University of Stuttgart




Make sure you are at the forefront of the big pharma and biotech industry. No matter where your interest lies, at the Americas Antibody Congress, World Immunotherapy Congress USA and World Biosimilar Congress USA, we have content, networking and potential partners for you. 

Download the brochure to find out exactly what's in store for this year's event.







To Sponsor Or Exhibit


Derek Cavanagh
t/ +44 (0)207 092 1297




To Speak


Joan Shutt
t/ +44 (0)207 092 1134




To Register


Tayyab Abbasi
t/ +44 (0)207 092 1210